Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversiesJosé María García Ruiz de Morales, Miguel Á. González‐Gay, L. Puig et al.|Autoimmunity Reviews|2019Cited by 334
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre StudyTiago Torres, Paolo Gisondi, Angelo Valerio Marzano et al.|American Journal of Clinical Dermatology|2024Cited by 58